In vivo targeted delivery of nanoparticles for theranosis

Accounts of Chemical Research

Volumn 44, Issue 10, 2011, Pages 1018-1028

  Koo, Heebeom ^a   Huh, Myung Sook ^a   Sun, In Cheol ^a   Yuk, Soon Hong ^b   Choi, Kuiwon ^a   Kim, Kwangmeyung ^a   Kwon, Ick Chan ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; NANOPARTICLE;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PHYSICAL CHEMISTRY; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS, INTRAVENOUS; NANOPARTICLES; PHYSICOCHEMICAL PROCESSES; RECEPTORS, CELL SURFACE;

EID: 80054758422     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar2000138     Document Type: Review

References (62)

1. Thakare, V. S.; Das, M.; Jain, A. K.; Patil, S.; Jain, S. Carbon nanotubes in cancer theragnosis Nanomedicine 2010, 5, 1277-1301
2. Nie, S.; Xing, Y.; Kim, G. J.; Simons, J. W. Nanotechnology applications in cancer Annu. Rev. Biomed. Eng. 2007, 9, 257-288 (Pubitemid 350246658)
3. Liu, Y.; Miyoshi, H.; Nakamura, M. Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles Int. J. Cancer 2007, 120, 2527-2537 (Pubitemid 46651272)
4. Willmann, J. K.; van Bruggen, N.; Dinkelborg, L. M.; Gambhir, S. S. Molecular imaging in drug development Nat. Rev. Drug Discovery 2008, 7, 591-607 (Pubitemid 351927724)
5. Nune, S. K.; Gunda, P.; Thallapally, P. K.; Lin, Y.-Y.; Laird Forrest, M.; Berkland, C. J. Nanoparticles for biomedical imaging Expert Opin. Drug Delivery 2009, 6, 1175-1194
6. Allen, T. M.; Cullis, P. R. Drug delivery systems: Entering the mainstream Science 2004, 303, 1818-1822 (Pubitemid 38374867)
7. Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Delivery Rev. 2008, 60, 1615-1626
8. Janib, S. M.; Moses, A. S.; MacKay, J. A. Imaging and drug delivery using theranostic nanoparticles Adv. Drug Delivery Rev. 2010, 62, 1052-1063
9. Park, K.; Lee, S.; Kang, E.; Kim, K.; Choi, K.; Kwon, I. C. New generation of multifunctional nanoparticles for cancer imaging and therapy Adv. Funct. Mater. 2009, 19, 1553-1566
10. Lee, J.-H.; Lee, K.; Moon, Seung, H.; Lee, Y.; Park, Tae, G.; Cheon, J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery Angew. Chem., Int. Ed. 2009, 48, 4174-4179
11. Choi, J.-S.; Lee, J.-H.; Shin, T.-H.; Song, H.-T.; Kim, E. Y.; Cheon, J. Self-confirming "AND" logic nanoparticles for fault-free MRI J. Am. Chem. Soc. 2010, 132, 11015-11017
12. Xie, J.; Lee, S.; Chen, X. Nanoparticle-based theranostic agents Adv. Drug Delivery Rev. 2010, 62, 1064-1079
13. Phillips, M. A.; Gran, M. L.; Peppas, N. A. Targeted nanodelivery of drugs and diagnostics Nano Today 2010, 5, 143-159
14. Fox, M. E.; Szoka, F. C.; Fréchet, J. M. J. Soluble polymer carriers for the treatment of cancer: The importance of molecular architecture Acc. Chem. Res. 2009, 42, 1141-1151
15. Jun, Y.-W.; Seo, J.-W.; Cheon, J. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences Acc. Chem. Res. 2008, 41, 179-189
16. Petros, R. A.; DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discovery 2010, 9, 615-627
17. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Controlled Release 2010, 148, 135-146
18. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 2001, 41, 189-207
19. Koch, A. E. Angiogenesis: Implications for rheumatoid arthritis Arthritis Rheum. 1998, 41, 951-962 (Pubitemid 28265398)
20. Saravanakumar, G.; Min, K. H.; Min, D. S.; Kim, A. Y.; Lee, C.-M.; Cho, Y. W.; Lee, S. C.; Kim, K.; Jeong, S. Y.; Park, K.; Park, J. H.; Kwon, I. C. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: Synthesis, characterization, and in vivo biodistribution J. Controlled Release 2009, 140, 210-217
21. Nam, T.; Park, S.; Lee, S.-Y.; Park, K.; Choi, K.; Song, I. C.; Han, M. H.; Leary, J. J.; Yuk, S. A.; Kwon, I. C.; Kim, K.; Jeong, S. Y. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging Bioconjugate Chem. 2010, 21, 578-582
22. Lee, S. J.; Koo, H.; Lee, D.-E.; Min, S.; Lee, S.; Chen, X.; Choi, Y.; Leary, J. F.; Park, K.; Jeong, S. Y.; Kwon, I. C.; Kim, K.; Choi, K. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system Biomaterials 2011, 32, 4021-4029
23. Kim, K.; Kim, J. H.; Park, H.; Kim, Y.-S.; Park, K.; Nam, H.; Lee, S.; Park, J. H.; Park, R.-W.; Kim, I.-S.; Choi, K.; Kim, S. Y.; Park, K.; Kwon, I. C. Tumor-homing multifunctional nanoparticles for cancer theranosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring J. Controlled Release 2010, 146, 219-227
24. Cho, Y. W.; Park, S. A.; Han, T. H.; Son, D. H.; Park, J. S.; Oh, S. J.; Moon, D. H.; Cho, K.-J.; Ahn, C.-H.; Byun, Y.; Kim, I.-S.; Kwon, I. C.; Kim, S. Y. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications Biomaterials 2007, 28, 1236-1247 (Pubitemid 44816372)
25. Park, K.; Kim, J.-H.; Nam, Y. S.; Lee, S.; Nam, H. Y.; Kim, K.; Park, J. H.; Kim, I.-S.; Choi, K.; Kim, S. Y.; Kwon, I. C. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles J. Controlled Release 2007, 122, 305-314 (Pubitemid 47404663)
26. Lee, B. S.; Park, K.; Park, S.; Kim, G. C.; Kim, H. J.; Lee, S.; Kil, H.; Oh, S. J.; Chi, D.; Kim, K.; Choi, K.; Kwon, I. C.; Kim, S. Y. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: Importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug J. Controlled Release 2010, 147, 253-260
27. Farokhzad, O. C.; Karp, J. M.; Langer, R. Nanoparticle-aptamer bioconjugates for cancer targeting Expert Opin. Drug Delivery 2006, 3, 311-324 (Pubitemid 43772708)
28. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15549-15554 (Pubitemid 47502954)
29. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 2006, 66, 6732-6740 (Pubitemid 44085631)
30. Ladner, R. C.; Sato, A. K.; Gorzelany, J.; de Souza, M. Phage display-derived peptides as therapeutic alternatives to antibodies Drug Discovery Today 2004, 9, 525-529 (Pubitemid 38739333)
31. Hong, H.-Y.; Lee, H. Y.; Kwak, W.; Yoo, J.; Na, M.-H.; So, I. S.; Kwon, T.-H.; Park, H.-S.; Huh, S.; Oh, G. T.; Kwon, I.-C.; Kim, I.-S.; Lee, B.-H. Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis J. Cell. Mol. Med. 2008, 12, 2003-2014
32. Park, K.; Hong, H.-Y.; Moon, H. J.; Lee, B.-H.; Kim, I.-S.; Kwon, I. C.; Rhee, K. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides J. Controlled Release 2008, 128, 217-223
33. Kawakami, M.; Kawakami, K.; Stepensky, V. A.; Maki, R. A.; Robin, H.; Muller, W.; Husain, S. R.; Puri, R. K. Interleukin 4 receptor on human lung cancer Clin. Cancer. Res. 2002, 8, 3503-3511
34. Wu, X. L.; Kim, J. H.; Koo, H.; Bae, S. M.; Shin, H.; Kim, M. S.; Lee, B.-H.; Park, R.-W.; Kim, I.-S.; Choi, K.; Kwon, I. C.; Kim, K.; Lee, D. S. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy Bioconjugate Chem. 2010, 21, 208-213
35. Lapčik, L.; De Smedt, S.; Demeester, J.; Chabreček, P. Hyaluronan: Preparation, structure, properties, and applications Chem. Rev. 1998, 98, 2663-2684
36. Lee, H.; Lee, K.; Park, T. G. Hyaluronic acid-Paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity Bioconjugate Chem. 2008, 19, 1319-1325 (Pubitemid 351874956)
37. Kim, K. S.; Hur, W.; Park, S.-J.; Hong, S. W.; Choi, J. E.; Goh, E. J.; Yoon, S. K.; Hahn, S. K. Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots ACS Nano 2010, 4, 3005-3014
38. Toole, B. P. Hyaluronan: From extracellular glue to pericellular cue Nat. Rev. Cancer 2004, 4, 528-539 (Pubitemid 38868622)
39. Choi, K. Y.; Min, K. H.; Na, J. H.; Choi, K.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: Synthesis, characterization, and in vivo biodistribution J. Mater. Chem. 2009, 19, 4102-4107
40. Choi, K. Y.; Chung, H.; Min, K. H.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 2010, 31, 106-114
41. Fang, J.; Seki, T.; Maeda, H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation Adv. Drug Delivery Rev. 2009, 61, 290-302
42. Lee, S.; Xie, J.; Chen, X. Peptides and peptide hormones for molecular imaging and disease diagnosis Chem. Rev. 2010, 110, 3087-3111
43. Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. A review of stimuli-responsive nanocarriers for drug and gene delivery J. Controlled Release 2008, 126, 187-204
44. Koo, H.; Huh, M. S.; Ryu, J. H.; Lee, D.-E.; Sun, I.-C.; Choi, K.; Kim, K.; Kwon, I. C. Nanoprobes for biomedical imaging in living systems Nano Today 2011, 6, 204-220
45. Ferrari, L. A.; Giannuzzi, L. Clinical parameters, postmortem analysis and estimation of lethal dose in victims of a massive intoxication with diethylene glycol Forensic Sci. Int. 2005, 153, 45-51 (Pubitemid 41008651)
46. Schneider, L.; Korber, A.; Grabbe, S.; Dissemond, J. Influence of pH on wound-healing: A new perspective for wound-therapy? Arch. Dermatol. Res. 2007, 298, 413-420 (Pubitemid 46144202)
47. Lindner, D.; Raghavan, D. Intra-tumoural extra-cellular pH: A useful parameter of response to chemotherapy in syngeneic tumour lines Br. J. Cancer 2009, 100, 1287-1291
48. Huang, Y.; McNamara, J. O. Ischemic stroke: "Acidotoxicity" is a perpetrator Cell 2004, 118, 665-666
49. Ko, J.; Park, K.; Kim, Y.-S.; Kim, M. S.; Han, J. K.; Kim, K.; Park, R.-W.; Kim, I.-S.; Song, H. K.; Lee, D. S.; Kwon, I. C. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly([beta]-amino ester) block copolymer micelles for cancer therapy J. Controlled Release 2007, 123, 109-115 (Pubitemid 47562136)
50. Ko, J. Y.; Park, S.; Lee, H.; Koo, H.; Kim, M. S.; Choi, K.; Kwon, I. C.; Jeong, S. Y.; Kim, K.; Lee, D. S. pH-sensitive nanoflash for tumoral acidic pH imaging in live animals Small 2010, 6, 2539-2544
51. Gao, G. H.; Im, G. H.; Kim, M. S.; Lee, J. W.; Yang, J.; Jeon, H.; Lee, J. H.; Lee, D. S. Magnetite-nanoparticle-encapsulated pH-responsive polymeric micelle as an MRI probe for detecting acidic pathologic areas Small 2010, 6, 1201-1204
52. Koo, H.; Lee, H.; Lee, S.; Min, K. H.; Kim, M. S.; Lee, D. S.; Choi, Y.; Kwon, I. C.; Kim, K.; Jeong, S. Y. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles Chem. Commun. 2010, 46, 5668-5670
53. Afjehi-Sadat, L.; Gruber-Olipitz, M.; Felizardo, M.; Slavc, I.; Lubec, G. Expression of proteasomal proteins in ten different tumor cell lines Amino Acids 2004, 27, 129-140 (Pubitemid 39506571)
54. Funovics, M.; Weissleder, R.; Tung, C.-H. Protease sensors for bioimaging Anal. Bioanal. Chem. 2003, 377, 956-963 (Pubitemid 40877826)
55. Merchan, J. R.; Tang, J.; Hu, G.; Lin, Y.; Mutter, W.; Tong, C.; Karumanchi, S. A.; Russell, S. J.; Sukhatme, V. P. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model J. Natl. Cancer Inst. 2006, 98, 756-764 (Pubitemid 43983299)
56. Lee, S.; Xie, J.; Chen, X. Peptide-based probes for targeted molecular imaging Biochemistry 2010, 49, 1364-1376
57. Chau, Y.; Padera, R. F.; Dang, N. M.; Langer, R. Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models Int. J. Cancer 2006, 118, 1519-1526
58. Lee, S.; Cha, E.-J.; Park, K.; Lee, S.-Y.; Hong, J.-K.; Sun, I.-C.; Kim, Sang, Y.; Choi, K.; Kwon, I. C.; Kim, K.; Ahn, C.-H. A near-infrared- fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination Angew. Chem., Int. Ed. 2008, 47, 2804-2807
59. Lee, S.; Ryu, J. H.; Park, K.; Lee, A.; Lee, S.-Y.; Youn, I.-C.; Ahn, C.-H.; Yoon, S. M.; Myung, S.-J.; Moon, D. H.; Chen, X.; Choi, K.; Kwon, I. C.; Kim, K. Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo Nano Lett. 2009, 9, 4412-4416
60. Kim, D.-E.; Kim, J.-Y.; Schellingerhout, D.; Kim, E.-J.; Kim, H. K.; Lee, S.; Kim, K.; Kwon, I. C.; Shon, S.-M.; Jeong, S.-W.; Im, S.-H.; Lee, D. K.; Lee, M. M.; Kim, G.-E. Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging Arterioscler., Thromb., Vasc. Biol. 2010, 30, 449-456
61. Maurer-Jones, M. A.; Bantz, K. C.; Love, S. A.; Marquis, B. J.; Haynes, C. L. Toxicity of therapeutic nanoparticles Nanomedicine 2009, 4, 219-241
62. Yeatman, T. J.; Mule, J.; Dalton, W. S.; Sullivan, D. On the eve of personalized medicine in oncology Cancer Res. 2008, 68, 7250-7252